Ftse Mib
33.946,19
0,19%
DAX
18.937,09
-0,27%
S&P 500
5.732,93
0,25%
NASDAQ
18.074,52
0,00%
Bitcoin
63.730,39
-0,84%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aclarion Inc (ACONW) Aclarion Inc (ACONW) Notizie

Aclarion Inc

ACONW
0,037984
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:17:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/9/202422:58EDGAR2Form 8-K - Current report
24/9/202422:54EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/9/202422:01EDGAR2Form 8-K - Current report
19/9/202423:02EDGAR2Form S-3/A - Registration statement under Securities Act of..
12/9/202412:57GLOBEAclarion Provides Corporate Update on Nociscan AI Technology..
10/9/202412:57GLOBEAclarion Announces Completion of First Nociscan Exams in..
05/9/202412:57GLOBEAclarion Launches Surgeon Partnership to Apply Nociscan’s AI..
29/8/202412:57GLOBEAclarion Launches Second Clinical Utility and Economic..
21/8/202413:57GLOBEAclarion Launches the Clinical Utility and Economic (CLUE)..
15/8/202415:48GLOBEAclarion to Present at August 20th Virtual Investor Summit..
14/8/202414:08GLOBEAclarion Announces First Commercial Agreement in Michigan
13/8/202415:07GLOBEAclarion Hits Another Key Milestone by Adding Vitality -..
09/7/202413:00GLOBEAclarion Achieves Milestone With Key Second Payer Coverage..
26/6/202414:30GLOBEAclarion Announces Initial Payer Coverage of Nociscan by AXA..
25/6/202414:30GLOBEAclarion Expands Commercial Engagement With The London..
18/6/202422:01EDGAR2Form 8-K - Current report
15/5/202421:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/4/202415:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
04/3/202414:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
27/2/202421:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
26/2/202415:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
05/2/202414:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
22/1/202414:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/1/202414:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
08/1/202414:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
02/1/202418:00GLOBEAclarion Announces Reverse Stock Split
27/11/202314:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
08/11/202314:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
06/11/202314:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
01/11/202313:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
25/10/202314:30GLOBEAclarion Announces Signing of Commercial Agreement With..
24/10/202314:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
23/10/202313:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
02/10/202314:00GLOBEAclarion Provides Updated Investor Presentation and..
Apertura: Min: Max:
Chiusura: 0,037984

La tua Cronologia

NASDAQ
ACONW
Aclarion
LSE
0LTF
Energoaparatura
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network